+499.5%
MRNA vs PAAS
+54.7%
+444.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PAAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.4% | +0.2% | -0.5% |
| 7D | +5.5% | -2.9% | +8.4% | +7.2% |
| 30D | +158.7% | +6.8% | +151.9% | +147.8% |
| 3M | +182.1% | -2.9% | +185.0% | +176.9% |
| 6M | +151.8% | -16.4% | +168.2% | +157.2% |
| YTD | +393.6% | 0.0% | +393.5% | +375.1% |
| 1Y | +499.5% | +54.3% | +445.1% | +429.0% |
| All | +499.5% | +54.7% | +444.8% | +429.0% |
Cumulative growth
Daily Returns
Daily percentage return beside PAAS.
Daily Out/Under-Performance
Portfolio return minus PAAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PAAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling